Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial

M LAMBERTINI; F POGGIO; M BRUZZONE; BENEDETTA CONTE; C BIGHIN; AZAMBUJA E DE; M GIULIANO; LAURENTIIS M DE; F COGNETTI; A FABI; G BISAGNI; A DURANDO; A TURLETTI; Y URRACCI; O GARRONE; F PUGLISI; F MONTEMURRO; I M CEPP; MASTRO L DEL

Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial

M LAMBERTINI, F POGGIO, M BRUZZONE, BENEDETTA CONTE, C BIGHIN, AZAMBUJA E DE, M GIULIANO, LAURENTIIS M DE, F COGNETTI, A FABI, G BISAGNI, A DURANDO, A TURLETTI, Y URRACCI, O GARRONE, F PUGLISI, F MONTEMURRO, I M CEPP, MASTRO L DEL

Dipartimento di Medicina Traslazionale

Risultato della ricerca: Contributo su rivista › Articolo in rivista

Lingua originale	Inglese
Rivista	International Journal of Cancer
Stato di pubblicazione	Pubblicato - 2020

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

https://hdl.handle.net/11579/192946

Altri file e collegamenti

handle

Cita questo

LAMBERTINI, M., POGGIO, F., BRUZZONE, M., CONTE, BENEDETTA., BIGHIN, C., DE, AZAMBUJA. E., GIULIANO, M., DE, LAURENTIIS. M., COGNETTI, F., FABI, A., BISAGNI, G., DURANDO, A., TURLETTI, A., URRACCI, Y., GARRONE, O., PUGLISI, F., MONTEMURRO, F., CEPP, I. M., & DEL, MASTRO. L. (2020). Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial. International Journal of Cancer. https://hdl.handle.net/11579/192946

@article{5da7fb93cdf545e3a92187e160d1c150,

title = "Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial",

author = "M LAMBERTINI and F POGGIO and M BRUZZONE and BENEDETTA CONTE and C BIGHIN and DE, {AZAMBUJA E} and M GIULIANO and DE, {LAURENTIIS M} and F COGNETTI and A FABI and G BISAGNI and A DURANDO and A TURLETTI and Y URRACCI and O GARRONE and F PUGLISI and F MONTEMURRO and CEPP, {I M} and DEL, {MASTRO L}",

year = "2020",

language = "English",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "John Wiley and Sons Inc.",

}

LAMBERTINI, M, POGGIO, F, BRUZZONE, M, CONTE, BENEDETTA, BIGHIN, C, DE, AZAMBUJAE, GIULIANO, M, DE, LAURENTIISM, COGNETTI, F, FABI, A, BISAGNI, G, DURANDO, A, TURLETTI, A, URRACCI, Y, GARRONE, O, PUGLISI, F, MONTEMURRO, F, CEPP, IM & DEL, MASTROL 2020, 'Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial', International Journal of Cancer. <https://hdl.handle.net/11579/192946>

TY - JOUR

T1 - Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial

AU - LAMBERTINI, M

AU - POGGIO, F

AU - BRUZZONE, M

AU - CONTE, BENEDETTA

AU - BIGHIN, C

AU - DE, AZAMBUJA E

AU - GIULIANO, M

AU - DE, LAURENTIIS M

AU - COGNETTI, F

AU - FABI, A

AU - BISAGNI, G

AU - DURANDO, A

AU - TURLETTI, A

AU - URRACCI, Y

AU - GARRONE, O

AU - PUGLISI, F

AU - MONTEMURRO, F

AU - CEPP, I M

AU - DEL, MASTRO L

PY - 2020

Y1 - 2020

UR - https://iris.uniupo.it/handle/11579/192946

M3 - Article

SN - 0020-7136

JO - International Journal of Cancer

JF - International Journal of Cancer

ER -